Avanos Medical, Inc.

Company AVNS

Last mentioned: Feb 26, 2026

Timeline

  1. 2026 Outlook

    Analysts adjust projections based on Q4 performance and AI integration.

  2. Earnings Release

    Avanos, Clarivate, and Leonardo DRS report Q4 2025 results.

  3. Q4 Strategy Launch

    Companies initiate final quarter strategies for the 2025 fiscal year.

Stories mentioning Avanos Medical, Inc. 3

earnings Neutral

Leonardo DRS and Clarivate Signal Strong Q4 SaaS and Defense Tech Growth

Leonardo DRS and Clarivate reported robust Q4 2025 results, highlighting a surge in demand for integrated defense electronics and AI-driven analytics. These results underscore a broader trend of increased technology spending in mission-critical sectors like national security and intellectual property management.

3 sources
market-trends Neutral

MedTech and Data Intelligence Resilience: Q4 2025 Earnings Analysis

Avanos Medical and Clarivate Plc reported Q4 2025 results highlighting a shift toward high-margin specialized medical devices and AI-driven life sciences analytics. Despite macroeconomic headwinds, these entities demonstrate a sector-wide pivot toward operational efficiency and data-centric healthcare solutions.

3 sources